000283117 001__ 283117
000283117 005__ 20260103103704.0
000283117 0247_ $$2doi$$a10.1002/alz70861_108159
000283117 0247_ $$2ISSN$$a1552-5260
000283117 0247_ $$2ISSN$$a1552-5279
000283117 037__ $$aDZNE-2026-00013
000283117 082__ $$a610
000283117 1001_ $$0P:(DE-2719)9003486$$aÖzlü, Serap$$b0$$eFirst author$$udzne
000283117 1112_ $$aAlzheimer’s Association International Conference$$cToronto$$d2025-07-27 - 2025-07-31$$gAAIC 25$$wCanada
000283117 245__ $$aCSF Biomarkers of Neuroinflammation in Prediction of Brain Atrophy
000283117 260__ $$c2025
000283117 3367_ $$0PUB:(DE-HGF)1$$2PUB:(DE-HGF)$$aAbstract$$babstract$$mabstract$$s1767355036_32513
000283117 3367_ $$033$$2EndNote$$aConference Paper
000283117 3367_ $$2BibTeX$$aINPROCEEDINGS
000283117 3367_ $$2DRIVER$$aconferenceObject
000283117 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$mjournal
000283117 3367_ $$2DataCite$$aOutput Types/Conference Abstract
000283117 3367_ $$2ORCID$$aOTHER
000283117 520__ $$aBackgroundInflammation is recognized as a key hallmark of Alzheimer’s disease (AD), alongside amyloid beta (Aβ) accumulation and tau pathology. Recent evidence suggests that neuroinflammatory markers in cerebrospinal fluid (CSF) are associated with progressive neurodegeneration and regional brain atrophy. In this study, we investigated the relationship between CSF inflammatory markers and atrophy in the basal forebrain and hippocampus longitudinally.MethodWe included 296 participants (37 with AD dementia, 69 with mild cognitive impairment (MCI), 98 with subjective cognitive decline (SCD) and 92 healthy control) from the DELCODE study. Data included baseline CSF markers, the Aβ42-phosphotau181 ratio, disease diagnosis, ApoE4 status, and longitudinal structural MRI volumes for specific brain regions, with a mean follow-up of 19.8 months (SD = 16.7). Latent factors were previously derived via Bayesian confirmatory factor analysis from 14 CSF markers and classified into Synaptic, Microglia, Chemokine/Cytokine, and Complement groups. We used linear mixed-effects models to assess interactions between latent factors and time on brain regions-controlling for age, sex, education and ApoE4 status- and, based on our systematic review, examined whether neurogranin, sTREM2, ferritin, and YKL40 predicted longitudinal changes.ResultOur findings revealed significant interaction effects between specific biomarkers and regional brain atrophy. Longitudinal atrophy in the hippocampus was significantly associated with higher levels of the synaptic marker (β = -0.018, p = 0.004), sTREM2 (β = -0.012, p = 0.031), and YKL40 (β = -0.022, p = 0.0002). Similarly, increased levels of ferritin (β = -0.040, p = 0.024) and YKL40 (β = -0.041, p = 0.029) were predictive of longitudinal atrophy in the basal forebrain. In contrast, neurogranin and other latent factors—including microglia, chemokine/cytokine, and complement—did not show significant associations with atrophy in either brain region.ConclusionThese results suggest that certain biomarkers, particularly the synaptic latent factor and the individual markers sTREM2, ferritin, and YKL40, are predictive of longitudinal neurodegeneration in key brain regions vulnerable to Alzheimer's disease. The associations found with hippocampal and basal forebrain atrophy highlight the potential of these markers for tracking disease progression and improving early detection strategies.
000283117 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000283117 588__ $$aDataset connected to CrossRef, Journals: pub.dzne.de
000283117 7001_ $$0P:(DE-2719)9001307$$aGrazia, Alice$$b1$$udzne
000283117 7001_ $$0P:(DE-2719)2810283$$aDyrba, Martin$$b2$$udzne
000283117 7001_ $$0P:(DE-2719)2810593$$aBrosseron, Frederic$$b3$$udzne
000283117 7001_ $$0P:(DE-2719)2811351$$aBuerger, Katharina$$b4$$udzne
000283117 7001_ $$0P:(DE-2719)2000005$$aDüzel, Emrah$$b5$$udzne
000283117 7001_ $$0P:(DE-2719)9003016$$aHellmann-Regen, Julian David Nicolai$$b6$$udzne
000283117 7001_ $$0P:(DE-2719)2000032$$aJessen, Frank$$b7$$udzne
000283117 7001_ $$0P:(DE-2719)2812139$$aKleineidam, Luca$$b8$$udzne
000283117 7001_ $$0P:(DE-2719)2000055$$aLaske, Christoph$$b9$$udzne
000283117 7001_ $$0P:(DE-2719)2812234$$aPerneczky, Robert$$b10$$udzne
000283117 7001_ $$0P:(DE-2719)2811024$$aPeters, Oliver$$b11$$udzne
000283117 7001_ $$0P:(DE-2719)2811122$$aPriller, Josef$$b12$$udzne
000283117 7001_ $$0P:(DE-2719)2812825$$aRamirez, Alfredo$$b13$$udzne
000283117 7001_ $$0P:(DE-2719)2812035$$aSchneider, Anja$$b14$$udzne
000283117 7001_ $$0P:(DE-2719)2811324$$aSpottke, Annika$$b15$$udzne
000283117 7001_ $$0P:(DE-2719)2811275$$aSynofzik, Matthis$$b16$$udzne
000283117 7001_ $$0P:(DE-2719)2811317$$aWiltfang, Jens$$b17$$udzne
000283117 7001_ $$0P:(DE-2719)2000026$$aTeipel, Stefan$$b18$$eLast author$$udzne
000283117 773__ $$0PERI:(DE-600)2201940-6$$a10.1002/alz70861_108159$$gVol. 21, no. S7, p. e108159$$nS7$$pe108159$$tAlzheimer's and dementia$$v21$$x1552-5260$$y2025
000283117 8564_ $$uhttps://pub.dzne.de/record/283117/files/DZNE-2026-00013.pdf$$yOpenAccess
000283117 8564_ $$uhttps://pub.dzne.de/record/283117/files/DZNE-2026-00013.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000283117 909CO $$ooai:pub.dzne.de:283117$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9003486$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000283117 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001307$$aExternal Institute$$b1$$kExtern
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810283$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810593$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811351$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000005$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000283117 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9003016$$aExternal Institute$$b6$$kExtern
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000032$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812139$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b8$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000055$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b9$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812234$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b10$$kDZNE
000283117 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)2811024$$aExternal Institute$$b11$$kExtern
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811122$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b12$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812825$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b13$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812035$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b14$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811324$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b15$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811275$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b16$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811317$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b17$$kDZNE
000283117 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2000026$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b18$$kDZNE
000283117 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000283117 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2025-01-06
000283117 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000283117 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2025-01-06$$wger
000283117 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bALZHEIMERS DEMENT : 2022$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000283117 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2025-01-06
000283117 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2025-01-06
000283117 9201_ $$0I:(DE-2719)1510100$$kAG Teipel$$lClinical Dementia Research (Rostock /Greifswald)$$x0
000283117 9201_ $$0I:(DE-2719)1011303$$kAG Heneka$$lNeuroinflammation, Biomarker$$x1
000283117 9201_ $$0I:(DE-2719)1111015$$kClinical Research (Munich)$$lClinical Research (Munich)$$x2
000283117 9201_ $$0I:(DE-2719)5000006$$kAG Düzel$$lClinical Neurophysiology and Memory$$x3
000283117 9201_ $$0I:(DE-2719)1011102$$kAG Jessen$$lClinical Alzheimer’s Disease Research$$x4
000283117 9201_ $$0I:(DE-2719)1011201$$kAG Wagner$$lNeuropsychology$$x5
000283117 9201_ $$0I:(DE-2719)1210000$$kAG Gasser$$lParkinson Genetics$$x6
000283117 9201_ $$0I:(DE-2719)5000022$$kAG Dichgans$$lVascular Cognitive Impairment & Post-Stroke Dementia$$x7
000283117 9201_ $$0I:(DE-2719)5000007$$kAG Priller$$lTranslational Neuropsychiatry$$x8
000283117 9201_ $$0I:(DE-2719)1011101$$kPatient Studies (Bonn)$$lPatient Studies (Bonn)$$x9
000283117 9201_ $$0I:(DE-2719)1011305$$kAG Schneider$$lTranslational Dementia Research (Bonn)$$x10
000283117 9201_ $$0I:(DE-2719)1011103$$kAG Spottke$$lClinical Research Platform (CRP)$$x11
000283117 9201_ $$0I:(DE-2719)1410006$$kAG Wiltfang$$lMolecular biomarkers for predictive diagnostics of neurodegenerative diseases$$x12
000283117 980__ $$aabstract
000283117 980__ $$aVDB
000283117 980__ $$aUNRESTRICTED
000283117 980__ $$ajournal
000283117 980__ $$aI:(DE-2719)1510100
000283117 980__ $$aI:(DE-2719)1011303
000283117 980__ $$aI:(DE-2719)1111015
000283117 980__ $$aI:(DE-2719)5000006
000283117 980__ $$aI:(DE-2719)1011102
000283117 980__ $$aI:(DE-2719)1011201
000283117 980__ $$aI:(DE-2719)1210000
000283117 980__ $$aI:(DE-2719)5000022
000283117 980__ $$aI:(DE-2719)5000007
000283117 980__ $$aI:(DE-2719)1011101
000283117 980__ $$aI:(DE-2719)1011305
000283117 980__ $$aI:(DE-2719)1011103
000283117 980__ $$aI:(DE-2719)1410006
000283117 9801_ $$aFullTexts